Published in Cancer Weekly, March 2nd, 1998
APL is a bone marrow cancer that strikes about 3,000 people in the United States every year.
"This study gets at the exact biochemical and genetic cause of the uncontrolled cell growth in this leukemia," said Mitchell A. Lazar, MD, PhD, chief of the division of endocrinology, diabetes, and metabolism. "Understanding the molecular basis of this disease will teach us important lessons about cancer in general."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.